Sales and earnings declined during the fiscal 3rd quarter for Hoya Corp. (TYO:7741), which reported an overall profit gain for the period despite falling sales. The Japanese conglomerate’s life care segment, which includes its eye care and endoscopy businesses, reported pre-tax profits of roughly $123.6 million (¥12.89 billion) on sales of $700.5 million (¥78.71 billion) for […]
Hoya Corp.
Hoya picks up Performance Optics for $476m
UPDATED Oct. 13, 2016, with details on acquisition amount. Hoya Corp. (TYO:7741) said today it inked a deal to buy Performance Optics and its subsidiaries Vision Ease and Daemyung Optical for roughly $476 million. The ¥48.98 billion acquisition includes Performance Optics’ ophthalmic lens manufacturing business, which includes polycarbonate, photochromic, polarized and high index eyeglass lenses, according to Tokyo-based […]
Report: CVRx CEO Yared tapped for AdvaMed chairman | Personnel Moves for June 27, 2016
Report: CVRx CEO Yared tapped to succeed BD’s Forlenza as AdvaMed chairman Nadim Yared, the CEO of CVRx, is reportedly slated to replace Becton Dickinson (NYSE:BDX) chief executive Vincent Forlenza as chairman of AdvaMed, the medical device industry’s national lobby in Washington. It’s the 1st time the Advanced Medical Technology Assn. will have a small company’s […]
Pentax Medical picks up controlling stake in Simmedica
Hoya (TYO:7741) subsidiary Pentax Medical said today it acquired over 90% of the shares in Spanish and Portugeuese endoscopy and surgery product and service company Simmedica. Pentax Medical said it made the decision to acquire a majority ownership in the company based upon an increase in sales volume and service over the recent years. “I am delighted that […]
Senate report faults hospitals, device makers, FDA for deadly ‘superbug’ outbreaks
A report by Democrats on the U.S. Senate’s health committee issued this week blames hospitals, medical device companies and the FDA for the deadly outbreaks of so-called “superbug” infections linked to duodenoscopes. The devices are used for a procedure called endoscopic retrograde cholangiopancreatography, in which a reusable tube-like camera is inserted into the throat of […]
Hoya expands vision biz into Russian market
Hoya Corp. (TYO:7741) said today it is entering into the Russian market through the creation of Hoya Lens RUS LLC. The Japanese company said it sees “significant opportunities” in its Russian expansion, and hopes to become a leading provider of advanced eye-care tech and services. “We look forward to building on the success the Hoya brand has […]
FDA orders ‘scope makers to launch postmarket studies
The FDA today ordered a trio of Japanese duodenoscope makers to run post-market surveillance studies to evaluate how the devices are reprocessed in real-world conditions, after a deadly rash of so-called “superbug” outbreaks this year were linked to the devices. The string of deadly infections were attributed to duodenoscopes made by Olympus (TYO:7733), Fujifilm Holdings (TSE:4901) and Hoya‘s (TYO:7741) Pentax subsidiary. The devices are used for […]
Hoya’s Pentax Medical buys stake in Creo
Hoya (TYO:7741) subsidiary Pentax Medical said it agreed to buy a stake in U.K. electrosurgery device maker Creo Medical for an unspecified amount. The move is part of Pentax Medical’s plan to get into the endoscopic therapy device market, the Japan-based company said. “We are pleased to be investing in an organization with a proven record of […]